Tempest Therapeutics, Inc.
TPST
Revenue
55.00k
▼-26.00k▼-32.10%
3 Months ChangeAssets
42.17M
▼-2.21M▼-4.98%
3 Months ChangeLiabilities
25.23M
▲1.48M▲6.25%
3 Months ChangeFree Cash Flow
-7.35M
▲995.00k▲11.92%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-10
Form 8-K
ID: 0001193125-24-235598
2024-08-08
Form 10-Q
ID: 0000950170-24-094124
2024-08-08
Form 8-K
ID: 0000950170-24-094102
2024-06-20
Form 8-K
ID: 0001193125-24-164015
2024-06-14
Form 8-K
ID: 0001193125-24-161685
2024-05-09
Form 10-Q
ID: 0000950170-24-057072
2024-05-09
Form 8-K
ID: 0000950170-24-057047
2024-03-19
Form 8-K
ID: 0000950170-24-033464
2023-11-08
Form 10-Q
ID: 0000950170-23-061278
2023-11-08
Form 8-K
ID: 0000950170-23-061271